+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plegridy Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6103977
The plegridy market research report is one of a series of new reports that provides plegridy market statistics, including the plegridy industry's global market size, regional shares, competitors with a plegridy market share, detailed plegridy market segments, market trends and opportunities, and any further data you may need to thrive in the plegridy industry. This plegridy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising focus on personalized medicine, growth of home-based healthcare, increasing use of digital health tools, growing aging population, and rising insurance coverage. Major trends in the forecast period include digital health integration, combination therapies, advancement in drug delivery systems, telemedicine adoption, and artificial intelligence in multiple sclerosis management.

The rising prevalence of multiple sclerosis is expected to drive the growth of the plegridy market in the coming years. Multiple sclerosis is a chronic autoimmune condition where the immune system attacks the protective sheath around nerve fibers in the central nervous system, disrupting communication between the brain and the body. This leads to a variety of neurological symptoms. The increasing incidence of multiple sclerosis is due to a combination of environmental factors, improved diagnostic methods, greater awareness, and lifestyle factors such as obesity and vitamin D deficiency, particularly among women. Plegridy is used to reduce relapse rates and slow disease progression in multiple sclerosis patients by modulating the immune system. For example, in May 2024, the Multiple Sclerosis Trust in the UK reported that over 150,000 people are living with multiple sclerosis, with more than 7,100 new diagnoses each year. The number of cases has increased by up to 15% in various regions, especially among people in their 30s and 40s. As a result, the growing prevalence of multiple sclerosis is contributing to the rise of the Plegridy market.

The growth of the plegridy market is also expected to be influenced by the rise in healthcare spending. Healthcare spending covers all expenditures related to healthcare goods and services, including personal care, preventive services, and public health initiatives. The surge in healthcare spending is driven by factors such as population growth, an aging demographic, increasing chronic diseases, and rising costs for medical services and prescription drugs. Higher healthcare spending leads to greater access to treatments such as Plegridy, improves patient awareness, and strengthens healthcare infrastructure for managing multiple sclerosis. For instance, in August 2023, the National Health Service Confederation reported that the NHS England budget for the 2022-2023 fiscal year was $152.6 billion, with more than 70% allocated to integrated care boards. Therefore, the growing healthcare investment is contributing to the expansion of the Plegridy market.

The plegridy market is also benefiting from the increasing use of biologics. Biologics are complex drugs derived from living organisms, including proteins and antibodies, that target specific biological processes in the body. Their effectiveness in treating a wide range of diseases, advances in biotechnology, and a demand for more precise therapies are driving their use. Biologics have become a cornerstone in multiple sclerosis treatment, with Plegridy offering a more targeted, effective, and convenient option for patients. For example, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023 that pharmaceutical production in Europe grew by 4.95% in 2022, reaching $384.2 billion. This growing adoption of biologics is fueling the growth of the Plegridy market.

The key company operating in the plegridy market is Biogen Inc.

North America was the largest region in the plegridy market in 2024. The regions covered in plegridy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the plegridy market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Plegridy (generic name: peginterferon beta-1a) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), a chronic condition that affects the central nervous system. It helps to reduce the frequency of relapses and slows the progression of physical disability in individuals with MS.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary routes of administration for Plegridy are subcutaneous (SC) injection and intramuscular (IM) injection. Subcutaneous injection involves delivering the medication into the fatty tissue just under the skin using a short needle. This method is preferred for its convenience and gradual release of medication into the bloodstream. Patients can self-administer the medication through subcutaneous injection, making it a convenient option for managing relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS). Plegridy is distributed through various channels, including direct sales, online pharmacies, and wholesale distributors, and is utilized by hospitals and clinical research laboratories.

The plegridy market consists of sales of plegridy (peginterferon beta-1a) injection and auto-injectors (plegridy pen). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Plegridy Market Characteristics
3. Plegridy Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Plegridy Market Trends And Strategies5. Plegridy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Plegridy Growth Analysis And Strategic Analysis Framework
6.1. Global Plegridy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Plegridy Market Growth Rate Analysis
6.4. Global Plegridy Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Plegridy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Plegridy Total Addressable Market (TAM)
7. Global Plegridy Pricing Analysis & Forecasts
8. Plegridy Market Segmentation
8.1. Global Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Subcutaneous (SC) Injection
  • Intramuscular (IM) Injection
8.2. Global Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Secondary Progressive Multiple Sclerosis (SPMS) With Relapses
8.3. Global Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Direct Sales
  • Online Pharmacies
  • Wholesale Distributors
8.4. Global Plegridy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Hospitals
  • Clinical Research Laboratories
9. Global Plegridy Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Plegridy Market Regional And Country Analysis
10.1. Global Plegridy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Plegridy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Plegridy Market
11.1. Asia-Pacific Plegridy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Plegridy Market
12.1. China Plegridy Market Overview
12.2. China Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Plegridy Market
13.1. India Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Plegridy Market
14.1. Japan Plegridy Market Overview
14.2. Japan Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Plegridy Market
15.1. Australia Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Plegridy Market
16.1. South Korea Plegridy Market Overview
16.2. South Korea Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Plegridy Market
17.1. Western Europe Plegridy Market Overview
17.2. Western Europe Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Plegridy Market
18.1. UK Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Plegridy Market
19.1. Germany Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Plegridy Market
20.1. France Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Plegridy Market
21.1. Eastern Europe Plegridy Market Overview
21.2. Eastern Europe Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Plegridy Market
22.1. North America Plegridy Market Overview
22.2. North America Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Plegridy Market
23.1. USA Plegridy Market Overview
23.2. USA Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Plegridy Market
24.1. Canada Plegridy Market Overview
24.2. Canada Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Plegridy Market
25.1. South America Plegridy Market Overview
25.2. South America Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Plegridy Market
26.1. Middle East Plegridy Market Overview
26.2. Middle East Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Plegridy Market
27.1. Africa Plegridy Market Overview
27.2. Africa Plegridy Market, Segmentation By Roue Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Plegridy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Plegridy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Plegridy Market Competitive Landscape And Company Profiles
28.1. Plegridy Market Competitive Landscape
28.2. Plegridy Market Company Profiles
28.2.1. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Plegridy Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Plegridy Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Plegridy Market32. Recent Developments In The Plegridy Market
33. Plegridy Market High Potential Countries, Segments and Strategies
33.1 Plegridy Market In 2029 - Countries Offering Most New Opportunities
33.2 Plegridy Market In 2029 - Segments Offering Most New Opportunities
33.3 Plegridy Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright And Disclaimer

Executive Summary

Plegridy Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plegridy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for plegridy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plegridy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Roue Of Administration: Subcutaneous (SC) Injection; Intramuscular (IM) Injection
2) By Clinical Indication: Relapsing-Remitting Multiple Sclerosis (RRMS); Secondary Progressive Multiple Sclerosis (SPMS) With Relapses
3) By Distribution Channel: Direct Sales; Online Pharmacies; Wholesale Distributors
4) By End User: Hospitals; Clinical Research Laboratories

Key Companies Profiled: Biogen Inc.

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Biogen Inc.